introduction: differentiated thyroid carcinoma (dtc) is associated with excellent prognosis and high survival rates. this study was conducted to evaluate the influence of baseline and treatment-related factors on the health related quality of life (qol) in cured dtc. methods:this study was an analytic cross-sectional study on radio-iodine (rai) treated dtc patients during 2011-2012. the data on...

AIM To evaluate the tolerability and efficacy of sorafenib in patients with thyroid carcinoma. METHODS Patients with progressive locally advanced/metastatic medullary thyroid carcinoma (MTC), or differentiated thyroid carcinoma (DTC) with non-radioiodine-avid disease, were treated with sorafenib 400 mg twice daily until disease progression. The primary endpoint was the radiological response r...

Introduction:Differentiated thyroid carcinoma (DTC) follow-up after thyroidectomy and radioiodine-ablation is performed mainly by thyroglobulin (Tg), diagnostic iodine-131 whole body scan (DxWBS) and sonography. Some patients with undetectable Tg have thyroid-bed uptake after ablation in whom decision making regarding the need for retreatment is still controversial. Me...

radioiodine (1-131) is the treatment of choice in differentiated thyroid carcinoma. external radiotlierapy however, has it's own roie in these tumors. treatment of anaplastic thyroid carcinoma 1ms not acliieved any notahle success yet, though combined - modality regimens of radiotherapy and chemotherapy have sometimes shown significant results. in this paper the role of radiotlierapy and chemot...

Differentiated thyroid carcinoma (DTC) comprises over 90% of thyroid tumors and includes papillary and follicular carcinomas. Patients with DTC have an excellent prognosis, with a 10-year survival rate of over 90%. However, the risk of recurrent tumor ranges between 5% and 30% within 10 years of the initial diagnosis. Cervical lymph node disease accounts for the majority of recurrences and in m...

Sternal metastasis from differentiated thyroid carcinoma (DTC) is rare and presents a conundrum for surgeons. We present a lady diagnosed with follicular thyroid carcinoma and sternal metastasis who underwent thyroidectomy, sternectomy and sternoplasty with titanium mesh and acrylic plate. She developed a surgical site infection, of which multiple conservative approaches were attempted. She eve...

Coexistence of differentiated thyroid cancer (DTC) and thyroid autoimmune diseases could represent a mere coincidence due to the frequent occurrence of autoimmunity, but there may also be a pathological and causative link between the two conditions. The coincidence of DTC with Hashimoto's disease has been variably reported at between 0.5 and 22.5% and of DTC with Graves' disease between 0 and 9...

BACKGROUND The loss of 131I uptake ability in metastases from differentiated thyroid carcinoma (DTC) is becoming a major obstacle in radioiodine treatment. However, there is no effective way to screen for 131I uptake ability in metastases. The identification of differentially expressed proteins by serum proteomics may contribute to our understanding of the mechanisms underlying the dedifferenti...

introduction:differentiated thyroid carcinoma (dtc) follow-up after thyroidectomy and radioiodine-ablation is performed mainly by thyroglobulin (tg), diagnostic iodine-131 whole body scan (dxwbs) and sonography. some patients with undetectable tg have thyroid-bed uptake after ablation in whom decision making regarding the need for retreatment is still controversial. methods: in this study, we e...

The following case study presents the management of stage III Differentiated Thyroid Cancer (DTC) patient in an NHS hospital in London, UK during period of 2004-2005. Keywords—Differentiated Thyroid Cancer, Oncological Management, Papillary, Thyroid Cancer, Stage III.